1976 completed, 359 unknown, 251 terminated, 149 withdrawn. 2912 Phase 3, 485 Phase 2.
Follow RNA Virus Infections: new trials by email Literature Review of RNA Virus Infections trials Research Report on RNA Virus Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis D Hepalatide 2.1mg, Placebo of Hepalatide - Hepatitis D, Chronic | Phase 3 | Not yet recruiting | Shanghai HEP Pharmaceutical Co., Ltd. | 150 | 2027-06-01 | 2026-10-28 |
| Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikungunya Vaccines Compared to Separate Administration in Adults Aged 18 to 59 Years. DENGUE: Dengue 1,2,3,4 (attenuated) vaccine CHIKUNGUNYA: Chikungunya (CHIKV) live attenuated vaccine (VLA1555), DENGUE: Dengue 1,2,3,4 (attenuated) vaccine, Chikungunya (CHIKV) live attenuated vaccine (VLA1555) - Dengue, Chikungunya | Phase 3 | Not yet recruiting | Butantan Institute | 900 | 2027-03-31 | 2026-07-16 |
| Reducing Arterial Inflammation Using Eplerenone and Statins in HIV Eplerenone, Placebo - HIV (Human Immunodeficiency Virus), Cardiovascular Diseases (CVD) | Phase 2 / Phase 3 | Not yet recruiting | Massachusetts General Hospital | 124 | 2027-03-01 | 2026-10-23 |
| Dapagliflozin for Long COVID Syndrome Dapagliflozin (DAPA), Placebo - COVID - 19, Long COVID Syndrome | Phase 3 | Not yet recruiting | Ottawa Heart Institute Research Corporation | 192 | 2026-12-01 | 2026-10-30 |
| The Study of Brave-LC LDN Treatment Trial naltrexone, Placebo - Post-acute COVID-19 Syndrome | Phase 3 | Not yet recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 1300 | 2026-11-16 | 2026-11-04 |
| Study of a Combination SARS-CoV-2 Recombinant Spike and High-Dose Inactivated Influenza Vaccine With Matrix-M Adjuvant in Adult Participants 60 Years of Age and Older IIV-HD (standalone), NVXC19 (EU licensed, standalone), IIV-HD + NVXC19 combination - Immunization, Healthy Volunteers | Phase 3 | Not yet recruiting | Sanofi | 6000 | 2026-11-09 | 2026-10-22 |
| An Adaptive Platform Trial for Evaluation of Novel Treatment Regimens in Children and Adolescents With HIV in Africa Dolutegravir (DTG), Abacavir (ABC), Lamivudine (3TC) - HIV Infection | Phase 3 | Not yet recruiting | University College, London | 800 | 2026-11-01 | 2026-08-28 |
| Evaluation of the Efficacy and Safety of 102D-6 in the Treatment of Acute Uncomplicated Influenza 20 mg 102D-6 dry suspension, 40 mg 102D-6 dry suspension, Placebo - Influenza, Human | Phase 2 / Phase 3 | Not yet recruiting | Capital Medical University | 570 | 2026-10-21 | 2026-10-26 |
| Study of Vaccines Against Bundibugyo Virus Disease in Contacts of Cases in the Democratic Republic of the Congo Candidate BDBV vaccine, Active comparator - Ebola Hemorrhagic Fever, Bundibugyo Virus Disease | Phase 2 / Phase 3 | Not yet recruiting | Jean-Pierre Van geertruyden | 3620 | 2026-10-20 | 2026-10-05 |
| A Study to Confirm Efficacy of a Single Dose of Baloxavir Marboxil in the Post-exposure Prophylaxis (PEP) of Influenza Virus Infection in Chinese Participants Baloxavir marboxil, Placebo - Influenza, Human, Respiratory Tract Infections | Phase 3 | Recruiting | Hoffmann-La Roche | 325 | 2026-10-16 | 2026-10-22 |
| Therapeutics for Moderate and Severe Dengue Placebo, Dexamethasone, N-Acetylcysteine - Dengue, Severe Dengue | Phase 3 | Not yet recruiting | Oxford University Clinical Research Unit, Vietnam | 8800 | 2026-10-01 | 2026-04-21 |
| A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age mRNA Seasonal Flu vaccine, Comparator 1, Comparator 2 - Influenza, Human | Phase 3 | Recruiting | GlaxoSmithKline | 3000 | 2026-10-01 | 2026-10-09 |
| Study of BK1803 in Healthy Infants BK1803, GOBIK Aqueous Suspension Syringes, Bimmugen® Injection - Pertussis, Diphtheria | Phase 3 | Not yet recruiting | Tanabe Pharma Corporation | 344 | 2026-10-01 | 2026-08-28 |
| Phase 2/3 Clinical Trial to Evaluate the Immunogenicity and Safety of GC3114B in Adults Aged 65 Years or Older vaccination of GC3114B, Vaccination of Efluelda - Influenza A, Influenza B, Influenza Vaccination | Phase 2 / Phase 3 | Not yet recruiting | GC Biopharma Corp | 1806 | 2026-10-01 | 2026-10-20 |
| Treatment of CKD Patients With HCV SOF+DCV, OBV/PTV/r) ± ribavirin (RBV) - HCV Infection ( Genotype 4) in CKD Patients | Phase 2 / Phase 3 | Not yet recruiting | Tanta University | 50 | 2026-09-15 | 2026-08-20 |
| A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease Secutrelvir, Placebo - SARS-CoV-2 | Phase 3 | Recruiting | Shionogi | 2000 | 2026-09-14 | 2026-11-03 |
| A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age mRNA Seasonal Flu vaccine, Licensed Influenza Vaccine - Influenza, Human | Phase 3 | Recruiting | GlaxoSmithKline | 54000 | 2026-09-02 | 2026-09-18 |
| Emetine for Viral Outbreaks (a.k.a. EVOLVE Antiviral Initiative) Emetine Hydrochloride 6mg, Placebo, Emetine Hydrochloride 12mg - Dengue | Phase 2 / Phase 3 | Recruiting | Johns Hopkins University | 600 | 2026-09-01 | 2026-10-13 |
| Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma Pegylated liposomal doxorubicin, Paclitaxel - Kaposi Sarcoma, HIV-1-infection | Phase 3 | Not yet recruiting | AIDS Malignancy Consortium | 130 | 2026-09-01 | 2026-01-23 |
| Early Corticosteroids in Severe Influenza Pneumonia Dexametasone, Sodium chloride 0.9% (placebo) - Severe Influenza, Intensive Care (ICU) | Phase 3 | Not yet recruiting | Centre Hospitalier Régional Metz-Thionville | 544 | 2026-09-01 | 2026-08-28 |
Showing 20 of 2912. Sign in to see all of them.
COVID-19 (909) · HIV Infections (601) · Influenza, Human (430) · Hepatitis C (284) · Acquired Immunodeficiency Syndrome (269) · Hepatitis C, Chronic (201) · Coronavirus Infections (171) · Poliomyelitis (101) · Virus Diseases (74) · Diphtheria (67) · Severe Acute Respiratory Syndrome (66) · Tetanus (66) · Hepatitis B (61) · Infections (54) · Pneumonia (51)
Infections (2858) · Virus Diseases (2838) · Respiratory Tract Diseases (1456) · Respiratory Tract Infections (1427) · Blood-Borne Infections (1136) · Communicable Diseases (1135) · Lung Diseases (963) · Nidovirales Infections (944) · Coronaviridae Infections (942) · Pneumonia, Viral (914) · Pneumonia (912) · Coronavirus Infections (788) · Immune System Diseases (735) · Urogenital Diseases (735)
Ribavirin (203) · Influenza Vaccines (90) · Ritonavir (90) · peginterferon alfa-2a (89) · Hydroxychloroquine (83) · Standard of Care (75) · Lamivudine (71) · Zidovudine (67) · efavirenz (61) · peginterferon alfa-2b (55) · Sofosbuvir (53) · Lopinavir (52) · Tenofovir (50) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (48) · remdesivir (41)
GlaxoSmithKline (179) · National Institute of Allergy and Infectious Diseases (NIAID) (124) · Merck Sharp & Dohme LLC (99) · Sanofi Pasteur, a Sanofi Company (87) · Gilead Sciences (77) · ViiV Healthcare (52) · AbbVie (48) · Bristol-Myers Squibb (47) · Hoffmann-La Roche (37) · Novartis Vaccines (34) · French National Agency for Research on AIDS and Viral Hepatitis (33) · Pfizer (28) · Boehringer Ingelheim (26) · Assistance Publique - Hôpitaux de Paris (23) · ANRS, Emerging Infectious Diseases (21)
United States (948) · Spain (310) · France (301) · Canada (300) · Germany (284) · United Kingdom (245) · Brazil (223) · Italy (211) · Puerto Rico (199) · South Africa (189) · Mexico (173) · China (172) · Australia (171) · Belgium (170) · Russia (170)
PMID 34473343, PMID 35713300, PMID 35244208, PMID 36695483, PMID 30977945, PMID 37489818, PMID 30012435, PMID 30923816, PMID 31568620, PMID 34350582, PMID 37591523, PMID 29461687, PMID 30529905, PMID 29377566, PMID 29404492, PMID 33502773, PMID 40099800, PMID 28193518, PMID 34658014, PMID 25040192, PMID 25583164, PMID 26743093, PMID 27847279, PMID 30868245, PMID 31986264, PMID 32109013, PMID 32171076, PMID 33570583, PMID 33901188, PMID 35174470, PMID 35464483, PMID 35695334, PMID 36442063, PMID 39324693, PMID 18657709, PMID 19571722, PMID 24979445, PMID 25030060, PMID 25445400, PMID 25992639, PMID 26947564, PMID 27553375, PMID 29465480, PMID 29767684, PMID 32142651, PMID 32187464, PMID 32423584, PMID 32678530, PMID 32829410, PMID 33240091
2015 (34), 2014 (33), 2009 (21), 2023 (20), 2016 (15), 2019 (15), 2008 (10), 2018 (10), 2025 (8), U24TR001608 (8), 2004 (7), 2005 (7), 2017 (6), U01CA121947 (4), U01AI068636 (3)